← All companies
Moderna, Inc.
MRNA - CIK 0001682852
Market cap$18.25 B
Rank#650
SEC filings1,447
The table below shows Moderna, Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $2.60B | $1.93B | $2.91B | $3.21B | $6.85B | $2.62B |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $184.00M | $358.00M | $892.00M | $1.39B | $3.17B | $1.39B |
| Inventory | $153.00M | $117.00M | $202.00M | $949.00M | $1.44B | $46.53M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.